glibenclamide - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
DAONIL glibenclamide 5mg tablet blister pack AUST R: 73683Active ingredients:
glibenclamide
Dosage form:
Tablet, uncoated
Sponsor:
Sanofi-Aventis Australia Pty Ltd
Phone:
1800818806
|
Deletion from market:
30 Nov 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options.
|